Prostaglandin biology
Crofford, L.J.
Gastroenterology Clinics of North America 30(4): 863-876
2001
ISSN/ISBN: 0889-8553 PMID: 11764532 Document Number: 536342
PGs are important mediators of normal physiology, response to injury, and pathologic processes. Dissecting these biochemical and molecular pathways allows development of therapeutic agents that can be [figure: see text] applied to specific clinical situations, while preserving PGs that play a role in normal physiology.
Document emailed within 1 workday
Related Documents
Sharif, N.A.; Xu, S.X.; Williams, G.W.; Crider, J.Y.; Griffin, B.W.; Davis, T.L. 1998: Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data Journal of Pharmacology and Experimental Therapeutics 286(2): 1094-1102Watanabe, K.; Iguchi, Y.; Iguchi, S.; Arai, Y.; Hayaishi, O.; Roberts, L.J. 1986: Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase Proceedings of the National Academy of Sciences of the United States of America 83(6): 1583-1587
Gaasterland, T.; Vingron, M. 2011: This special issue comprises the papers accepted for presentationat the 19th Annual International Conference on Intelligent Systemsfor Molecular Biology, joint with the 10th European Conference on Computational Biology, an official conference of the InternationalSociety for Computational Biology Bioinformatics 27(13): I1
Arai, N.; Yokota, T.; de Vries, J.; Banchereau, J.; Takebe, Y.; Lee, F.; Arai, K. 1988: Molecular biology of T cell-derived lymphokines: structure and biology of interleukin 4 Developments in Biological Standardization 69: 57-63
Glimcher, M.J.; Kenzora, J.E. 1979: Nicolas Andry award. The biology of osteonecrosis of the human femoral head and its clinical implications: 1. Tissue biology Clinical orthopaedics and related research 1979(138): 284-309
Morchio, R. 2002: Conditions for a theoretical biology: is biology truly an autonomous science? Rivista di Biologia 95(1): 149-157
Bousquet, B.; Charret, J.; Dreux, C.; Gaudeau-Toussaint, M.F.; Gruson, A.; Marcelli, A.; de Mouy, D.; Plaisance, J.J.; Sachs, C.; Trivin, F.; Valdiguié, P.; Zerah, S. 1998: Thoughts and recommendations concerning the accreditation of hospital and private medical biology laboratories. Working Group of the French Society of Clinical Biology Annales de Biologie Clinique 56(4): 504-507
Jaffe, B.M.; Parker, C.W.; Philpott, G.W. 1971: Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal and neoplastic cultured tissue Surgical Forum 22: 90-92
Retzke, U.; Schwarz, R. 1976: Cardiovascular effects of intravenous infusions of prostaglandin F2 alpha prostaglandin E2 in early pregnancy Acta Biologica et Medica Germanica 35(8-9): 1249-1250
Perryman, D.; Yeast, J.D.; Holst, V. 1992: Cervical ripening: a randomized study comparing prostaglandin E2 gel to prostaglandin E2 suppositories Obstetrics and Gynecology 79(5): 670-672
Gao, W.; Schmidtko, A.; Wobst, I.; Lu, R.; Angioni, C.; Geisslinger, G. 2009: Prostaglandin D2 produced by hematopoietic prostaglandin D synthase contributes to LPS-induced fever Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 60(2): 145-150
Nagappa, A.N.; Raju, D.B.; Srivastava, R.C. 1989: Role of liquid membrane phenomenon in the biological actions of prostaglandins: studies on prostaglandin E1 and prostaglandin F2 alpha Indian Journal of Biochemistry and Biophysics 26(3): 172-177
Rolland, P.H.; Martin, P.M.; Rolland, A.M.; Bourry, M.; Serment, H. 1979: Benign breast disease: studies of prostaglandin E2, steroids, and thermographic effects of inhibitors of prostaglandin biosynthesis Obstetrics and Gynecology 54(6): 715-718
Minami, T.; Okuda-Ashitaka, E.; Mori, H.; Ito, S.; Hayaishi, O. 1996: Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice Journal of Pharmacology and Experimental Therapeutics 278(3): 1146-1152
Gorbunova, A.V.; Gan'shina, T.S.; Gretskaia, N.M.; Bezuglov, V.V.; Mirzoian, R.S. 2013: Cerebrovascular effects of GABA-prostaglandin E2 conjugate in comparison with prostaglandin E2 Eksperimental'naia i Klinicheskaia Farmakologiia 76(8): 13-16
Wasinger, T. 1989: Prostaglandin receptors and prostaglandin metabolism in the terminal circulation of the brain Wiener Klinische Wochenschrift 101(23): 821-824
Berry, C.N.; Hoult, J.R.; Phillips, J.A.; McCarthy, T.M.; Agback, H. 1985: Highly potent inhibition of prostaglandin 15-hydroxydehydrogenase in-vitro and of prostaglandin inactivation in perfused lung by the new azobenzene analogue, Ph CL 28A Journal of Pharmacy and Pharmacology 37(9): 622-628
Shimkovich, M.V.; Pshennikova, M.G. 1986: Effect of preliminary administration of prostaglandin E2 and the prostaglandin synthesis inhibitor indomethacin on disturbances of myocardial contraction during stress Biulleten' Eksperimental'noi Biologii i Meditsiny 101(5): 536-537
Parsons, W.G.; Roberts, L.J. 1988: Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. a potential mast cell-eosinophil interaction Journal of Immunology 141(7): 2413-2419
Service, R.F. 2001: The human genome. Objection #1: big biology is bad biology Science 291(5507): 1182